SOUTH KOREA · OPENDART
Macrogen, Inc.
마크로젠 · 038290 · KOSDAQ · Healthcare · Diagnostics & Research
Score
Not ranked: no net buying on the exchange by an individual insider in the last 180 days.
Insider trades on the exchange
Purchases and sales on the exchange in the last 12 months. The filing gives the settlement date; the trade date is two trading days earlier.
No exchange purchase by an insider is on record yet.
Other changes in holdings · 8
Option exercises, grants, new shares, inheritance, gifts, off-exchange trades and trades by companies and funds. Not counted in the score.
| Date | Insider | Role | Reason | Shares | Filing |
|---|---|---|---|---|---|
| 2026-09-23 | Shin Sang-heum | G6 | New report(+) | 2,203 | DART ↗ |
| 2025-12-31 | CHU, CHANG NAM | Vice president | Executive retirement(-) | 10,000 | DART ↗ |
| 2025-01-31 | KIM JONG YOON | Vice president | 임원퇴임(-) | 2,192 | DART ↗ |
| 2025-01-17 | SUNGSUP SIM | Managing director | 신규보고(+) | 95 | DART ↗ |
| 2025-01-17 | Hong Seok Ju | Managing director | 신규보고(+) | 20 | DART ↗ |
| 2025-01-14 | Sei Woong Yoon | President | 신규보고(+) | 800 | DART ↗ |
| 2024-12-31 | Sangjoon Hwang | Adviser | 임원퇴임(-) | 1,500 | DART ↗ |
| 2024-12-26 | Seo Jeong Sun | Chairman | 장외매수(+) | 862,343 | DART ↗ |